An Observational Study of Dutasteride and Alpha-blocker Combination Therapy in Men With Symptomatic Benign Prostatic Hyperplasia and PSA Level Over 4 ng/mL

Dutasteride and Flex Dose of Tamsulosin on as Needed Basis, to Treat Benign Prostatic Hyperplasia

NCT00701779 ·Status: COMPLETED ·Phase: PHASE4

A Study to Determine the Bioavailability of a Fixed Dose Combination Product of Dutasteride (0.5mg) and Tamsulosin Hydrochloride (0.2mg) Relative to Co-administration of the Individual Components in Healthy Male Subjects of North East Asian and Non-Asian Ancestry.

NCT01254071 ·Status: COMPLETED ·Phase: PHASE1

Α Prospective Observational Study for the Evaluation of Disease Control and Quality of Life in Patients With Benign PROStatic hyPERplasia Under Fixed Dose combΙnaTion Treatment With Dutasteride and Tamsulosin . PROSPERITY Group of Studies (I&II)

NCT04831476 ·Status: COMPLETED

Effects of Alpha Blockers on Prostate-specific Antigen (PSA) Change in Men With Lower Urinary Tract Symptoms (LUTS)

NCT01250483 ·Status: COMPLETED

Advanced Benefits of Alpha-blocker Monotherapy on Lower Urinary Tracts Symptoms(LUTS) Patients

NCT01736033 ·Status: UNKNOWN ·Phase: PHASE4

Dutasteride 0.5mg For The Treatment Of Chinese Patients With Benign Prostatic Hyperplasia (BPH)

NCT00527605 ·Status: COMPLETED ·Phase: PHASE3

Effects On Dihydrotestosterone Regulated Gene Expression In Benign Prostatic Hyperplasia Or Prostate Cancer

NCT00375765 ·Status: COMPLETED ·Phase: PHASE4

Safety and Efficacy of 0.5mg Dutasteride and 0.4mg Tamsulosin Combination Once Daily for Six Months for Benign Prostatic Hyperplasia

NCT01673490 ·Status: TERMINATED ·Phase: PHASE4

Comparison Between Alpha Blocker Monotherapy and 5ARI Monotherapy Following Combination Therapy in Benign Prostatic Hyperplasia (BPH)

NCT01301599 ·Status: COMPLETED ·Phase: PHASE4

Prospective Sexual Function Study for BPH Subjects

NCT01777269 ·Status: COMPLETED ·Phase: PHASE4

Efficacy and Safety of DKF-313 in Patients With Benign Prostatic Hyperplasia

NCT04947631 ·Status: COMPLETED ·Phase: PHASE3

The Changes of Urine Growth Factors Level

NCT06282731 ·Status: COMPLETED ·Phase: EARLY_PHASE1

Comparative Efficacy of Dutasteride Plus Tamulosin With Lifestyle Advice Versus Watchful Waiting Plus Lifestyle Advice in the Management of Treatment naïve Men With Moderately Symptomatic Benign Prostatic Hyperplasia and Prostate Enlargement

NCT01294592 ·Status: COMPLETED ·Phase: PHASE4

Evaluation of the Potential Association Between 5α-reductase Inhibitors Prescription and Occurrence of High Grade Prostate Cancers

NCT02873117 ·Status: COMPLETED

Effect Of Dutasteride On Intraprostatic Dihydrotestosterone (DHT) Levels

NCT00062790 ·Status: COMPLETED ·Phase: PHASE4

A Study to Determine the Improvement of the Symptoms of Benign Prostatic Hyperplasia (BPH) When Switching Subjects From Proscar to Avodart

NCT00690950 ·Status: UNKNOWN ·Phase: PHASE4

Dutasteride With Tolterodine ER or Placebo to Treat Lower Urinary Tract Symptoms (LUTS)

NCT00939120 ·Status: COMPLETED ·Phase: PHASE4

Combination Statin, Acetylsalicylic Acid and Dutasteride Use in Prostate Cancer

NCT01428869 ·Status: COMPLETED

Bioequivalence Study of the Second Generation Dutasteride and Tamsulosin Hydrochloride (HCL) Combination Capsule in Fasted State

NCT02052713 ·Status: COMPLETED ·Phase: PHASE1

Antimuscarinics as the First-line Treatment for Male With IPSS-V/S≤1

NCT01661621 ·Status: COMPLETED ·Phase: PHASE4

Clinical Progression and Costs in Benign Prostatic Hyperplasia Patients Treated With Early Versus Delayed Combination Therapy

NCT01435954 ·Status: COMPLETED

Role of Dutasteride in Treatment of Chronic Prostatitis

NCT04756206 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

Treatment of Refractory Urinary Retention Secondary to Benign Prostatic Hyperplasia (BPH) With Dual Five Alpha Reductase Inhibition Combined With an Alpha Blocker

NCT00680680 ·Status: COMPLETED ·Phase: NA

Long-term Effects of Dutasteride on Architectural and Nuclear Morphometric Features of Benign Prostate Tissue

NCT01473030 ·Status: COMPLETED

Dutasteride for Improving Peri-Operative and Long-Term Outcomes of Photoselective Vaporization of the Prostate (DOP)

NCT00274417 ·Status: UNKNOWN ·Phase: NA